|
Partnering
considerations are integral to an emerging life science
company’s business strategy. CHI’s Biotech Pharma
Partnership provides companies with a unique opportunity
to gain insight into how to successfully initiate,
negotiate, and maintain a partnering agreement. This
one-day, pre-conference workshop will identify best
practices for effective partnership. Through instructive
lectures and an interactive panel, a faculty of seasoned
professionals will provide vital
"how-to" information and advice.
Confirmed
Faculty:
Michael T. Clark, Ph.D., Senior Director, Strategic
Alliances, Pfizer Global Research and Development
Teresa N. Faria, Ph.D., Associate Director, Alliance
Management, Bristol-Myers Squibb
Stefanie A. Hansen, J.D., Director, Strategic Alliances,
Pfizer Worldwide Business Development
Rekha Hemrajani, Senior Director of Corporate Business
Development, Exelixis
John P. Iwanicki, Esq., Senior Partner, Banner & Witcoff,
Ltd.
G. Garrett Vygantas, M.D., Senior Associate, Burrill &
Company
David A. Zarling,
Ph.D., M.B.A., Chief Executive Officer, Colby Pharma
10:15 am Opening
Remarks
10:25 Partnering
for a Healthier World
Michael T. Clark, Ph.D., Senior Director, Strategic
Alliances, Pfizer Global Research and Development
-
Why partner?
-
What does
Pfizer partner for?
-
Who does Pfizer
partner with?
-
What process do
we go through to partner with a 3rd party?
10:55 Positioning,
Preparing, & Presenting Your Very Small Pharma Company
to Big Pharma: Drug Data, Diligence Package, and Partnering
Strategies Building Pharma's Interest, Respect, &
Trust
David A. Zarling, Ph.D., M.B.A., Chief Executive
Officer, Colby Pharma
11:40 Networking
Coffee Break
12:00 pm Approaching
Potential Partners: How To Capture the Attention of a
Potential Partner and Increase Your Chances of Securing a
Deal
G. Garrett Vygantas, M.D., Senior Associate, Burrill
& Company
-
Know thyself
and your potential partner:
What type of organization is your target partner, and
what is their current and future corporate strategy?
What are they looking for?
What is your competitive advantage? IP position?
-
Approaching a
partner: Perfecting the pitch
-
Follow-up best
practices: What can help you versus put you at a
disadvantage?
12:30 Avoiding
IP Surprises
John P. Iwanicki, Esq., Senior Partner, Banner &
Witcoff, Ltd.
-
Due diligence
before collaborating
-
Joint
collaboration agreements and sorting out who owns what
-
Material
transfer agreements and reach through rights
-
Licensing
know-how and show-how
1:15 Lunch on
Your Own
2:30 Opening
Remarks
2:35 Case Study:
Transforming a Company through Partnerships
Rekha Hemrajani, Senior Director of Corporate Business
Development, Exelixis
How Exelixis has:
3:05 Alliance
Management: How Can Large and Small Companies Work Together?
Teresa N. Faria, Ph.D., Associate Director, Alliance
Management, Bristol-Myers Squibb
3:35 Adapting to
a Shifting Industry: How Are Deals Evolving?
Stefanie A. Hansen, J.D., Director, Strategic Alliances,
Pfizer Worldwide Business Development
-
Companies are
reaching out more than ever to fill their pipelines
-
More
competition for products and platforms
-
Biotech
business plans and goals are changing
-
Deals are
getting earlier -- reaching into preclinical and
IND-stage compounds
-
Deals are
becoming more complex
-
More use of
quids/out-licensing
4:05 Networking
Refreshment Break
4:25 Interactive
Panel Discussion, Q&A with Faculty Advisors
Speakers take the floor to field your questions, which may
include those related to:
Commercialization
and market positioning
...and more!
5:25 Closing Remarks
5:30 Close of The
Biotech Pharma Partnership
|
